Laboratoires Euromedis Société anonyme (EPA:ALEMG)
France · Delayed Price · Currency is EUR 5.50
0.00 (0.00%)
Nov 5, 2026, 5:00 PM CET
EPA:ALEMG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 43.22 | 40.85 | 36.22 | 34.04 | 54.18 | 111.9 |
Other Revenue | -0.42 | 0.21 | 0.2 | 0.03 | 0 | - |
| 42.8 | 41.06 | 36.41 | 34.07 | 54.18 | 111.9 | |
Revenue Growth | 8.93% | 12.77% | 6.88% | -37.13% | -51.58% | -42.14% |
Cost of Revenue | 36.75 | 36.44 | 34.23 | 33.86 | 35.44 | 78.41 |
Gross Profit | 6.04 | 4.62 | 2.18 | 0.21 | 18.75 | 33.49 |
Selling, General & Admin | 2.97 | 2.6 | 3.1 | 4.21 | 25.35 | 27.23 |
Other Operating Expenses | 1.47 | 1.48 | -1.6 | 1.35 | -6.66 | -4.96 |
Operating Expenses | 5.42 | 4.31 | 1.72 | 5.77 | 23.88 | 29.3 |
Operating Income | 0.62 | 0.31 | 0.45 | -5.56 | -5.14 | 4.19 |
Interest Expense | -0.36 | -0.35 | -0.5 | -0.36 | -0.37 | -0.35 |
Interest & Investment Income | 0.42 | 0.42 | 0.62 | 27.78 | - | - |
Earnings From Equity Investments | - | - | - | - | 0.02 | 0.02 |
Currency Exchange Gain (Loss) | 0.17 | 0.17 | 0.03 | -0.02 | -0.03 | -0.08 |
Other Non Operating Income (Expenses) | -0.21 | 0 | -0.17 | -0.01 | 0.25 | 0.01 |
EBT Excluding Unusual Items | 0.63 | 0.55 | 0.43 | 21.83 | -5.27 | 3.79 |
Impairment of Goodwill | - | - | - | - | -0.09 | - |
Gain (Loss) on Sale of Assets | -0 | -0 | - | - | - | - |
Asset Writedown | - | - | - | 12.3 | -0.43 | -1.13 |
Other Unusual Items | 4.33 | - | -6.55 | -20.75 | -0.19 | -0.15 |
Pretax Income | 4.96 | 0.55 | -6.11 | 13.38 | -5.98 | 2.51 |
Income Tax Expense | 1.28 | 0.68 | -0 | 0.27 | -0.04 | 0.21 |
Earnings From Continuing Operations | 3.68 | -0.13 | -6.11 | 13.11 | -5.94 | 2.3 |
Minority Interest in Earnings | - | - | - | - | 0.01 | -0.05 |
Net Income | 3.68 | -0.13 | -6.11 | 13.11 | -5.93 | 2.26 |
Net Income to Common | 3.68 | -0.13 | -6.11 | 13.11 | -5.93 | 2.26 |
Net Income Growth | - | - | - | - | - | -90.05% |
Shares Outstanding (Basic) | - | 3 | 3 | 3 | 3 | 3 |
Shares Outstanding (Diluted) | - | 3 | 3 | 3 | 3 | 4 |
Shares Change | - | 0.39% | -0.17% | -2.55% | -18.41% | - |
EPS (Basic) | - | -0.05 | -2.15 | 4.60 | -2.03 | 0.75 |
EPS (Diluted) | - | -0.05 | -2.15 | 4.60 | -2.03 | 0.63 |
EPS Growth | - | - | - | - | - | -90.05% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | - | - | - | -2.08 | 17.41 |
Free Cash Flow Per Share | - | - | - | - | -0.71 | 4.86 |
Gross Margin | 14.12% | 11.25% | 5.98% | 0.62% | 34.60% | 29.93% |
Operating Margin | 1.46% | 0.77% | 1.25% | -16.31% | -9.48% | 3.75% |
Profit Margin | 8.59% | -0.32% | -16.78% | 38.48% | -10.95% | 2.02% |
Free Cash Flow Margin | - | - | - | - | -3.84% | 15.56% |
EBITDA | 1.61 | 0.53 | 0.68 | -4.44 | -4.01 | 5.2 |
EBITDA Margin | 3.76% | 1.30% | 1.86% | -13.02% | -7.41% | 4.64% |
D&A For EBITDA | 0.98 | 0.22 | 0.22 | 1.12 | 1.12 | 1 |
EBIT | 0.62 | 0.31 | 0.45 | -5.56 | -5.14 | 4.19 |
EBIT Margin | 1.46% | 0.77% | 1.25% | -16.31% | -9.48% | 3.75% |
Effective Tax Rate | 25.89% | 123.93% | - | 2.01% | - | 8.35% |
Revenue as Reported | 43.75 | 42.02 | 40.28 | 37.43 | 61.35 | 117.61 |